(S (NP (DT This) (NN paper)) (VP (VBZ proposes) (NP (NP (NNS entitymetrics)) (SBAR (S (VP (TO to) (VP (VB measure) (NP (NP (DT the) (NN impact)) (PP (IN of) (NP (NN knowledge) (NNS units)))))))))) (. .))
(S (NP (NNS Entitymetrics)) (VP (VBD highlight) (NP (NP (DT the) (NN importance)) (PP (IN of) (NP (NP (NNS entities)) (VP (VBN embedded) (PP (IN in) (NP (JJ scientific) (NN literature)))))) (PP (IN for) (NP (JJ further) (NN knowledge) (NN discovery))))) (. .))
(S (PP (IN In) (NP (DT this) (NN paper))) (, ,) (NP (PRP we)) (VP (VBP use) (NP (NP (NNP Metformin)) (, ,) (NP (NP (DT a) (NN drug)) (PP (IN for) (NP (NNS diabetes)))) (, ,)) (PP (IN as) (NP (DT an) (NN example))) (S (VP (TO to) (VP (VB form) (NP (NP (DT an) (NN entity-entity) (NN citation) (NN network)) (VP (VBN based) (PP (IN on) (NP (NP (NN literature)) (VP (VBN related) (PP (TO to) (NP (NNP Metformin)))))))))))) (. .))
(S (NP (PRP We)) (ADVP (RB then)) (VP (VP (VBP calculate) (NP (DT the) (NN network) (NNS features))) (CC and) (VP (VB compare) (NP (NP (DT the) (NN centrality) (NNS ranks)) (PP (IN of) (NP (JJ biological) (NNS entities)))) (PP (IN with) (NP (NP (NNS results)) (PP (IN from) (NP (NP (JJ Comparative) (NNS Toxicogenomics) (NNP Database)) (PRN (-LRB- -LRB-) (NP (NNP CTD)) (-RRB- -RRB-)))))))) (. .))
(S (NP (DT The) (NN comparison)) (VP (VBZ demonstrates) (NP (NP (DT the) (NN usefulness)) (PP (IN of) (NP (NNS entitymetrics))) (S (VP (TO to) (VP (VB detect) (NP (NP (JJS most)) (PP (IN of) (NP (NP (DT the) (JJ outstanding) (NNS interactions)) (VP (ADVP (RB manually)) (VBN curated) (PP (IN in) (NP (NNP CTD)))))))))))) (. .))
